MEKs/ERKs inhibitor U0126 increases the radiosensitivity of rhabdomyosarcoma cells in vitro and in vivo by down regulating growth and DNA repair signals

Multimodal treatment has improved the outcome of many solid tumors, and in some cases the use of radiosensitizers has significantly contributed to this gain. Activation of the extracellular signaling kinase pathway (MEK/ERK) generally results in stimulation of cell growth and confers a survival adva...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Marampon, Francesco, Gravina, Giovanni Luca, Di Rocco, Agnese, Bonfili, Pierluigi, Di Staso, Mario, Fardella, Caterina, Polidoro, Lorella, Ciccarelli, Carmela, Festuccia, Claudio, Popov, Vladimir M., Pestell, Richard G., Tombolini, Vincenzo, Zani, Bianca Maria
Format: Artigo
Jezik:Inglês
Izdano: 2011
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3064485/
https://ncbi.nlm.nih.gov/pubmed/21220498
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-10-0631
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki